Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC).
Selgai HaidariMatthias TröltzschRiham M FliefelAchim A JungbluthSven OttoFlorian FeggParis LiokatisNima AhmadiMarian EberlFlorian Andreas ProbstThomas KnöselPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2022)
PRAME is expressed in OSCC and appears to be a suitable marker of progression-free survival, correlates with severe course, and may allow identification of high-risk patients with aggressive progression.